Food

 

Report Published: "Global Cystic Fibrosis Therapeutics Market 2018-2022"



03.03.2018 21:23:37 - Recently published research from TechNavio, "Global Cystic Fibrosis Therapeutics Market 2018-2022", is now available at Fast Market Research

(live-PR.com) - CF is a genetic disorder that mostly affects the lungs and sometimes other parts of the body such as the liver, pancreas, intestines, and the kidneys. The disease is inherited in an autosomal recessive manner. It is due to mutations caused in both the copies of the gene for the CFTR protein.

Full Report Details at
- fastmr.com/products/1310571-global-cystic-fibros ..

Technavio's analysts forecast the

 

global cystic fibrosis therapeutics market to grow at a CAGR of 17.28% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global cystic fibrosis therapeutics market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

* Americas
* APAC
* EMEA

Technavio's report, Global Cystic Fibrosis Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* AbbVie
* Gilead
* F. Hoffmann-La Roche
* Vertex Pharmaceuticals

Market driver

* Improved diagnostic technologies
* For a full, detailed list, view our report

Market challenge

* Drug discontinuation
* For a full, detailed list, view our report

Market trend

* Strategic collaborations
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2022 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: AbbVie, Gilead, F. Hoffmann-La Roche, Vertex Pharmaceuticals

Partial Table of Contents:

Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
- Market outline
PART 05: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 06: MARKET SIZING
- Market definition
- Market sizing
- Market size and forecast
PART 07: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 08: MARKET SEGMENTATION BY DRUG CLASS
- Comparison by drug class
- CFTR modulators
- Mucolytics
- PERT
- Anti-infectives
- Bronchodilators
- Market opportunity by drug class
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
- Regional comparison
- CF therapeutics market in Americas
- CF therapeutics market in EMEA
- CF therapeutics market in APAC
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market Drivers
- Market challenges
PART 13: MARKET TRENDS
- Strategic collaborations
- Advances in technology for drug development and delivery
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- AbbVie
- Gilead
- F. Hoffmann-La Roche
- Vertex Pharmaceuticals
PART 16: APPENDIX
- List of abbreviations
List of Exhibits
Exhibit 01: Autosomal recessive pattern of inheritance in CF
Exhibit 02: Effects of CF on different body parts
Exhibit 03: Most common CFTR mutations
Exhibit 04: Global birth prevalence of CF by 2017
Exhibit 05: Diagnosis and treatment of CF
Exhibit 06: Parent market
Exhibit 07: Market characteristics
Exhibit 08: Market segments
Exhibit 09: Market definition: Inclusions and exclusions checklist
Exhibit 10: Market size
Exhibit 11: Validation techniques employed for market sizing 2017
Exhibit 12: Global CF therapeutics market 2017-2022 ($ millions)
Exhibit 13: Global CF therapeutics market: Year over year growth 2018-2022 (%)
Exhibit 14: Five forces analysis 2017
Exhibit 15: Five forces analysis 2022

Full Table of Contents is available at:
-- fastmr.com/products/1310571-global-cystic-fibros ..

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)


Author:
Bill Thompson
e-mail
Web: http://www.fastmr.com
Phone: 1.413.485.7001


 

Disclaimer: If you have any questions regarding information in this article please contact the author. Please do not contact Live-PR.com. We are not able to assist you. Live-PR.com disclaims content contained in this article. Live-PR.com is not authorized to give any information about content and not responsible for content posted by third party.
refer this article
Print This Article
Terms Of Use Privacy About Live-PR.com Contact Us